The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nanomedicines Market Research Report 2025

Global Nanomedicines Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1933775

No of Pages : 83

Ask Your Query

Synopsis

Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures.

The global Nanomedicines market was valued at US$ 155.5 million in 2023 and is anticipated to reach US$ 246.8 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.

Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.

This report aims to provide a comprehensive presentation of the global market for Nanomedicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanomedicines.

Report Scope

The Nanomedicines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanomedicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nanomedicines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Abbott
  • GE Healthcare
  • Johnson & Johnson
  • Merck
  • Pfizer
  • CombiMatrix
  • Celgene
  • Mallinckrodt
  • Sigma-Tau Pharmaceuticals
  • Teva Pharmaceutical
  • Nanosphere
  • UCB SA

Segment by Type

  • Nanoparticles
  • Nanoshells
  • Nanotubes
  • Nanodevices
  • Others

Segment by Application

  • Hospitals
  • Clinics
  • Research Institute

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanomedicines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomedicines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nanoparticles
1.2.3 Nanoshells
1.2.4 Nanotubes
1.2.5 Nanodevices
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nanomedicines Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institute
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicines Market Perspective (2019-2030)
2.2 Nanomedicines Growth Trends by Region
2.2.1 Global Nanomedicines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nanomedicines Historic Market Size by Region (2019-2024)
2.2.3 Nanomedicines Forecasted Market Size by Region (2025-2030)
2.3 Nanomedicines Market Dynamics
2.3.1 Nanomedicines Industry Trends
2.3.2 Nanomedicines Market Drivers
2.3.3 Nanomedicines Market Challenges
2.3.4 Nanomedicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicines Players by Revenue
3.1.1 Global Top Nanomedicines Players by Revenue (2019-2024)
3.1.2 Global Nanomedicines Revenue Market Share by Players (2019-2024)
3.2 Global Nanomedicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanomedicines Revenue
3.4 Global Nanomedicines Market Concentration Ratio
3.4.1 Global Nanomedicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomedicines Revenue in 2023
3.5 Nanomedicines Key Players Head office and Area Served
3.6 Key Players Nanomedicines Product Solution and Service
3.7 Date of Enter into Nanomedicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicines Breakdown Data by Type
4.1 Global Nanomedicines Historic Market Size by Type (2019-2024)
4.2 Global Nanomedicines Forecasted Market Size by Type (2025-2030)
5 Nanomedicines Breakdown Data by Application
5.1 Global Nanomedicines Historic Market Size by Application (2019-2024)
5.2 Global Nanomedicines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nanomedicines Market Size (2019-2030)
6.2 North America Nanomedicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nanomedicines Market Size by Country (2019-2024)
6.4 North America Nanomedicines Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanomedicines Market Size (2019-2030)
7.2 Europe Nanomedicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nanomedicines Market Size by Country (2019-2024)
7.4 Europe Nanomedicines Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicines Market Size (2019-2030)
8.2 Asia-Pacific Nanomedicines Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nanomedicines Market Size by Region (2019-2024)
8.4 Asia-Pacific Nanomedicines Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanomedicines Market Size (2019-2030)
9.2 Latin America Nanomedicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nanomedicines Market Size by Country (2019-2024)
9.4 Latin America Nanomedicines Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicines Market Size (2019-2030)
10.2 Middle East & Africa Nanomedicines Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nanomedicines Market Size by Country (2019-2024)
10.4 Middle East & Africa Nanomedicines Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Nanomedicines Introduction
11.1.4 Abbott Revenue in Nanomedicines Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Nanomedicines Introduction
11.2.4 GE Healthcare Revenue in Nanomedicines Business (2019-2024)
11.2.5 GE Healthcare Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Nanomedicines Introduction
11.3.4 Johnson & Johnson Revenue in Nanomedicines Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Nanomedicines Introduction
11.4.4 Merck Revenue in Nanomedicines Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Nanomedicines Introduction
11.5.4 Pfizer Revenue in Nanomedicines Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 CombiMatrix
11.6.1 CombiMatrix Company Detail
11.6.2 CombiMatrix Business Overview
11.6.3 CombiMatrix Nanomedicines Introduction
11.6.4 CombiMatrix Revenue in Nanomedicines Business (2019-2024)
11.6.5 CombiMatrix Recent Development
11.7 Celgene
11.7.1 Celgene Company Detail
11.7.2 Celgene Business Overview
11.7.3 Celgene Nanomedicines Introduction
11.7.4 Celgene Revenue in Nanomedicines Business (2019-2024)
11.7.5 Celgene Recent Development
11.8 Mallinckrodt
11.8.1 Mallinckrodt Company Detail
11.8.2 Mallinckrodt Business Overview
11.8.3 Mallinckrodt Nanomedicines Introduction
11.8.4 Mallinckrodt Revenue in Nanomedicines Business (2019-2024)
11.8.5 Mallinckrodt Recent Development
11.9 Sigma-Tau Pharmaceuticals
11.9.1 Sigma-Tau Pharmaceuticals Company Detail
11.9.2 Sigma-Tau Pharmaceuticals Business Overview
11.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Introduction
11.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2019-2024)
11.9.5 Sigma-Tau Pharmaceuticals Recent Development
11.10 Teva Pharmaceutical
11.10.1 Teva Pharmaceutical Company Detail
11.10.2 Teva Pharmaceutical Business Overview
11.10.3 Teva Pharmaceutical Nanomedicines Introduction
11.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business (2019-2024)
11.10.5 Teva Pharmaceutical Recent Development
11.11 Nanosphere
11.11.1 Nanosphere Company Detail
11.11.2 Nanosphere Business Overview
11.11.3 Nanosphere Nanomedicines Introduction
11.11.4 Nanosphere Revenue in Nanomedicines Business (2019-2024)
11.11.5 Nanosphere Recent Development
11.12 UCB SA
11.12.1 UCB SA Company Detail
11.12.2 UCB SA Business Overview
11.12.3 UCB SA Nanomedicines Introduction
11.12.4 UCB SA Revenue in Nanomedicines Business (2019-2024)
11.12.5 UCB SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Nanomedicines Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Nanoparticles
Table 3. Key Players of Nanoshells
Table 4. Key Players of Nanotubes
Table 5. Key Players of Nanodevices
Table 6. Key Players of Others
Table 7. Global Nanomedicines Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Nanomedicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Nanomedicines Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Nanomedicines Market Share by Region (2019-2024)
Table 11. Global Nanomedicines Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Nanomedicines Market Share by Region (2025-2030)
Table 13. Nanomedicines Market Trends
Table 14. Nanomedicines Market Drivers
Table 15. Nanomedicines Market Challenges
Table 16. Nanomedicines Market Restraints
Table 17. Global Nanomedicines Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Nanomedicines Market Share by Players (2019-2024)
Table 19. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicines as of 2023)
Table 20. Ranking of Global Top Nanomedicines Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Nanomedicines Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nanomedicines Product Solution and Service
Table 24. Date of Enter into Nanomedicines Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nanomedicines Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Nanomedicines Revenue Market Share by Type (2019-2024)
Table 28. Global Nanomedicines Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Nanomedicines Revenue Market Share by Type (2025-2030)
Table 30. Global Nanomedicines Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Nanomedicines Revenue Market Share by Application (2019-2024)
Table 32. Global Nanomedicines Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Nanomedicines Revenue Market Share by Application (2025-2030)
Table 34. North America Nanomedicines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Nanomedicines Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Nanomedicines Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Nanomedicines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Nanomedicines Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Nanomedicines Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Nanomedicines Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Nanomedicines Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Nanomedicines Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Nanomedicines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Nanomedicines Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Nanomedicines Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Nanomedicines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Nanomedicines Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Nanomedicines Market Size by Country (2025-2030) & (US$ Million)
Table 49. Abbott Company Detail
Table 50. Abbott Business Overview
Table 51. Abbott Nanomedicines Product
Table 52. Abbott Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 53. Abbott Recent Development
Table 54. GE Healthcare Company Detail
Table 55. GE Healthcare Business Overview
Table 56. GE Healthcare Nanomedicines Product
Table 57. GE Healthcare Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 58. GE Healthcare Recent Development
Table 59. Johnson & Johnson Company Detail
Table 60. Johnson & Johnson Business Overview
Table 61. Johnson & Johnson Nanomedicines Product
Table 62. Johnson & Johnson Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 63. Johnson & Johnson Recent Development
Table 64. Merck Company Detail
Table 65. Merck Business Overview
Table 66. Merck Nanomedicines Product
Table 67. Merck Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Pfizer Company Detail
Table 70. Pfizer Business Overview
Table 71. Pfizer Nanomedicines Product
Table 72. Pfizer Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. CombiMatrix Company Detail
Table 75. CombiMatrix Business Overview
Table 76. CombiMatrix Nanomedicines Product
Table 77. CombiMatrix Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 78. CombiMatrix Recent Development
Table 79. Celgene Company Detail
Table 80. Celgene Business Overview
Table 81. Celgene Nanomedicines Product
Table 82. Celgene Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 83. Celgene Recent Development
Table 84. Mallinckrodt Company Detail
Table 85. Mallinckrodt Business Overview
Table 86. Mallinckrodt Nanomedicines Product
Table 87. Mallinckrodt Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 88. Mallinckrodt Recent Development
Table 89. Sigma-Tau Pharmaceuticals Company Detail
Table 90. Sigma-Tau Pharmaceuticals Business Overview
Table 91. Sigma-Tau Pharmaceuticals Nanomedicines Product
Table 92. Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 93. Sigma-Tau Pharmaceuticals Recent Development
Table 94. Teva Pharmaceutical Company Detail
Table 95. Teva Pharmaceutical Business Overview
Table 96. Teva Pharmaceutical Nanomedicines Product
Table 97. Teva Pharmaceutical Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 98. Teva Pharmaceutical Recent Development
Table 99. Nanosphere Company Detail
Table 100. Nanosphere Business Overview
Table 101. Nanosphere Nanomedicines Product
Table 102. Nanosphere Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 103. Nanosphere Recent Development
Table 104. UCB SA Company Detail
Table 105. UCB SA Business Overview
Table 106. UCB SA Nanomedicines Product
Table 107. UCB SA Revenue in Nanomedicines Business (2019-2024) & (US$ Million)
Table 108. UCB SA Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanomedicines Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nanomedicines Market Share by Type: 2023 VS 2030
Figure 3. Nanoparticles Features
Figure 4. Nanoshells Features
Figure 5. Nanotubes Features
Figure 6. Nanodevices Features
Figure 7. Others Features
Figure 8. Global Nanomedicines Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Nanomedicines Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Research Institute Case Studies
Figure 13. Nanomedicines Report Years Considered
Figure 14. Global Nanomedicines Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Nanomedicines Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Nanomedicines Market Share by Region: 2023 VS 2030
Figure 17. Global Nanomedicines Market Share by Players in 2023
Figure 18. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicines as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Nanomedicines Revenue in 2023
Figure 20. North America Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Nanomedicines Market Share by Country (2019-2030)
Figure 22. United States Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Nanomedicines Market Share by Country (2019-2030)
Figure 26. Germany Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Nanomedicines Market Share by Region (2019-2030)
Figure 34. China Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Nanomedicines Market Share by Country (2019-2030)
Figure 42. Mexico Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Nanomedicines Market Share by Country (2019-2030)
Figure 46. Turkey Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Nanomedicines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 49. GE Healthcare Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 50. Johnson & Johnson Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 52. Pfizer Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 53. CombiMatrix Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 54. Celgene Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 55. Mallinckrodt Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 56. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 57. Teva Pharmaceutical Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 58. Nanosphere Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 59. UCB SA Revenue Growth Rate in Nanomedicines Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock